S66 — Star Combo Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- AU$15.53m
- AU$6.71m
- AU$26.28m
- 74
- 91
- 48
- 80
Annual cashflow statement for Star Combo Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.246 | 0.466 | 0.541 | 0.128 | 0.261 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.02 | 0.332 | 0.534 | 1.88 | -0.316 |
| Capital Expenditures | -2.78 | -7.26 | -7.29 | -2.73 | -1.44 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.845 | 9.68 | 4.05 | -0.5 | 1.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.63 | 2.42 | -3.24 | -3.23 | -0.137 |
| Financing Cash Flow Items | -8.34 | — | — | -0.201 | -0.207 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 26.6 | -2.08 | -0.169 | -0.053 | -0.371 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 22 | 0.671 | -2.88 | -1.41 | -0.824 |